Sign In
Buy NDRA
$4.70
+0.370 (+8.55%)
At Close: Jul 31, 2026
ENDRA Life Sciences to Report First Quarter 2021 Financial Results on May 17, 2021
08:00am, Thursday, 06'th May 2021
ANN ARBOR, MI / ACCESSWIRE / May 6, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results
NDRA Stock: From $2.31 To $2.40 (3.9% Increase) Pre-Market Explanation
09:18am, Tuesday, 04'th May 2021
The stock price of ENDRA Life Sciences Inc (NASDAQ: NDRA) increased from $2.31 to $2.40 (up 3.9%) pre-market. This is why it happened.
ENDRA Life Sciences Further Strengthens TAEUS(R) System's Intellectual Property Protection with Issuance of Two U.S. Patents
08:30am, Tuesday, 04'th May 2021
ANN ARBOR, MI / ACCESSWIRE / May 4, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the Company has recently been issued U.S. Paten
5 MedTech Outperformers With Nearly 40% or More Gain in 2021
09:50am, Friday, 16'th Apr 2021
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting
08:30am, Thursday, 08'th Apr 2021
ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the Company's Chief Techno
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q4 2020 Results - Earnings Call Transcript
09:05pm, Thursday, 25'th Mar 2021
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q4 2020 Results - Earnings Call Transcript
ENDRA Life Sciences to Report Fourth Quarter 2020 Financial Results on March 25, 2021
04:05pm, Wednesday, 17'th Mar 2021
ANN ARBOR, MI / ACCESSWIRE / March 17, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial resu
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
08:00am, Tuesday, 02'nd Mar 2021
ANN ARBOR, MI / ACCESSWIRE / March 2, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in t
NDRA Stock Price Increases Over 60% Pre-Market: Why It Happened
06:02am, Wednesday, 20'th Jan 2021
The stock price of ENDRA Life Sciences Inc (NASDAQ: NDRA) is trading at over 60% pre-market today. This is why it happened.
ENDRA Life Sciences Granted 13th U.S. Patent for its TAEUS(R) Platform Technology
09:00am, Wednesday, 13'th Jan 2021
Now Has 78 Patents Issued, Filed, Licensed or in Preparation As Taeus® Commercial Launch Plans Advance ANN ARBOR, MI / ACCESSWIRE / January 13, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA),
ENDRA Life Sciences to Present at H.C. Wainwright Virtual BioConnect 2021 Conference
09:00am, Friday, 08'th Jan 2021
ANN ARBOR, MI / ACCESSWIRE / January 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that Chairman and CEO Francois Mich
ENDRA Life Sciences Issued Chinese Patent for Its TAEUS(R) Platform Technology to Calculate Fat Concentration in Tissue
09:00am, Wednesday, 23'rd Dec 2020
ANN ARBOR, MI / ACCESSWIRE / December 23, 2020 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), has recently been issued Chinese Patent ZL
ENDRA Life Sciences Extends GE Healthcare Collaboration Agreement for Two Years
09:00am, Monday, 21'st Dec 2020
Supports Commercialization of TAEUS Ⓡ Product for Imaging NAFLD/NASH to December 2023 ANN ARBOR, MI / ACCESSWIRE / December 21, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of
ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
12:30pm, Friday, 18'th Dec 2020
ANN ARBOR, MI / ACCESSWIRE / December 18, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today reported the closing of its previously announc
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q3 2020 Results - Earnings Call Transcript
08:02pm, Monday, 16'th Nov 2020
ENDRA Life Sciences Inc. (NDRA) CEO Francois Michelon on Q3 2020 Results - Earnings Call Transcript
